search
Back to results

Assessment of the Effects of Synbiotic on Gut Microbiota Composition in Scholars With Overweight

Primary Purpose

Childhood Obesity, Childhood Overweight

Status
Completed
Phase
Not Applicable
Locations
Mexico
Study Type
Interventional
Intervention
Lactobacillus casei strain Shirota
Lactobacillus casei strain Shirota plus inulin
Lactobacillus casei strain Shirota plus fructans from A. salmiana
Sponsored by
Universidad Autonoma de San Luis Potosí
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Childhood Obesity focused on measuring Microbiota, Probiotic, Fermented milk product, Synbiotic

Eligibility Criteria

6 Years - 11 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Children were overweight or obese, according to the World Health Organization (≥85th body mass index (BMI) percentile for overweight, and ≥95th BMI percentile for obesity).

Exclusion Criteria:

  • Any known infections, systemic diseases or metabolic diseases, and use of any prescribed medications or antibiotics in the one month before randomization and during the trial.

Sites / Locations

  • Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Experimental

Arm Label

Lactobacillus casei (Probiotic)

L. casei strain Shirota plus inulin (Syn-Inulin)

L. casei strain Shirota plus fructans from A. salmiana (Syn-A. salmiana)

Arm Description

Consist in a commercial fermented milk food (Soful LT), which Lactobacillus casei was used as a primary base (probiotic product)

Consist in a commercial fermented milk food (Soful LT), which Lactobacillus casei was used as a primary base (probiotic product) and enriched with 3g of inulin.

Consist in a commercial fermented milk food (Soful LT), which Lactobacillus casei was used as a primary base (probiotic product) and enriched with 3g of fructans from A. salmiana.

Outcomes

Primary Outcome Measures

Gut bacteria associated with changes of the intervention group
Comparison of the log2ratio of the genera and the abundance of amplicon sequence variants across the different treatments.
Effect of probiotic and synbiotic products intervention on the BMI z-score
Assesment of BMI-Z score changes
Effect of probiotic and synbiotic products intervention on the fat percentage
Assesment of fat percentage changes
Effect of probiotic and synbiotic products intervention on waist and neck circunference
Assesment of waist and neck circunference changes
Effect of probiotic and synbiotic products intervention on glucose, triglycerides and cholesterol serum levels
Assesment of glucose, triglycerides and cholesterol serum levels changes

Secondary Outcome Measures

Effect of probiotic and synbiotic products intervention on Free Fatty Acid Receptors (FFAR) 2 and 3 levels
Assessment of mRNA levels of FFAR2 and FFAR3 in the peripheral blood mononuclear cells changes

Full Information

First Posted
June 9, 2022
Last Updated
June 14, 2022
Sponsor
Universidad Autonoma de San Luis Potosí
search

1. Study Identification

Unique Protocol Identification Number
NCT05423015
Brief Title
Assessment of the Effects of Synbiotic on Gut Microbiota Composition in Scholars With Overweight
Official Title
Elaboration and Assessment of the Effects of Synbiotic on Gut Microbiota Composition of Scholars With Overweight
Study Type
Interventional

2. Study Status

Record Verification Date
June 2022
Overall Recruitment Status
Completed
Study Start Date
July 21, 2017 (Actual)
Primary Completion Date
October 2, 2017 (Actual)
Study Completion Date
October 9, 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Universidad Autonoma de San Luis Potosí

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study was a randomized, double-blind controlled protocol in children overweight aged 6-11 years. This study aimed to evaluate the effect of consuming fermented milk products containing Lactobacillus casei strain Shirota (LcS), as a probiotic enriched with prebiotic fructans from A. salmiana or inulin-like standard commercial prebiotic to improve the gut microbiota modulation. After providing detailed information, written informed consent was obtained from parents and written and oral assent from participants before the initial test day. Children were eligible for inclusion in the trial if they were overweight according to the World Health Organization (≥85th body mass index (BMI) percentile for overweight). The trial took place in three full-time elementary schools in San Luis Potosí, México, and the screening of the prospective participants took place up to 1 week prior to the randomization. Children were evaluated over a 6-week intervention period receiving different fermented milk products
Detailed Description
Male and female children between the ages of 6- 10 years old were recruited from three schools located in San Luis Potosi, Mexico. According to the World Health Organization, children with overweight were requested to participate and were voluntarily recruited. After providing detailed information, written informed consent was obtained from parents and written and oral assent from participants before the initial test day. The trial investigated the effect of daily intake of fermented milk products containing Lactobacillus casei strain Shirota (LcS), LcS plus inulin (LcS+inulin), and LcS plus fructans from A. salmiana (LcS+fructans) on gut microbiota composition. The trial protocol was conducted according to the principles of the Declaration of Helsinki. It was approved by the Ethical Committee on Human Experimentation of the State Committee of Health Education and Research of the Health Secretary in San Luis Potosi (register number SLP/012-2017).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Childhood Obesity, Childhood Overweight
Keywords
Microbiota, Probiotic, Fermented milk product, Synbiotic

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Randomised, double blind controlled protocol in children with overweight or obesity aged 6-11 years
Masking
ParticipantInvestigator
Masking Description
The enrolled children were randomized to the three groups in a 1:1:1 ratio stratified by age at the time of study enrolment. The study's investigators and clinical staff were blinded until the final database. Only appointed staff had access to the randomization list to perform labeling of the study products.
Allocation
Randomized
Enrollment
37 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Lactobacillus casei (Probiotic)
Arm Type
Experimental
Arm Description
Consist in a commercial fermented milk food (Soful LT), which Lactobacillus casei was used as a primary base (probiotic product)
Arm Title
L. casei strain Shirota plus inulin (Syn-Inulin)
Arm Type
Experimental
Arm Description
Consist in a commercial fermented milk food (Soful LT), which Lactobacillus casei was used as a primary base (probiotic product) and enriched with 3g of inulin.
Arm Title
L. casei strain Shirota plus fructans from A. salmiana (Syn-A. salmiana)
Arm Type
Experimental
Arm Description
Consist in a commercial fermented milk food (Soful LT), which Lactobacillus casei was used as a primary base (probiotic product) and enriched with 3g of fructans from A. salmiana.
Intervention Type
Dietary Supplement
Intervention Name(s)
Lactobacillus casei strain Shirota
Other Intervention Name(s)
L. casei Shirota, LcS, Probiotic product
Intervention Description
Probiotic product were made in a Class II biosafety cabinet. Fifteen milliliters of the fermented milk food wich contains LcS were taken with a sterile syringe, and, at a subsequent time, 15 mL of sterile water were added to the probiotic product.
Intervention Type
Dietary Supplement
Intervention Name(s)
Lactobacillus casei strain Shirota plus inulin
Other Intervention Name(s)
LcS + inulin, Synbiotic product, Syn-inulin
Intervention Description
The Syn-inulin products were made in a Class II biosafety cabinet. Fifteen milliliters of the fermented milk food wich contains LcS were taken with a sterile syringe, and, at a subsequent time, 3 g of inulin (BENEO GmbH) were diluted in 15 mL of sterile water and added to Syn-inulin products.
Intervention Type
Dietary Supplement
Intervention Name(s)
Lactobacillus casei strain Shirota plus fructans from A. salmiana
Other Intervention Name(s)
Lactobacillus casei strain Shirota plus A.salmiana, LcS + fructans, LcS + A. salmiana, Synbiotic product, Syn- A. salmiana
Intervention Description
The Syn-A. salmiana products were made in a Class II biosafety cabinet. Fifteen milliliters of the fermented milk food wich contains LcS were taken with a sterile syringe, and, at a subsequent time, 3 g of fructans from A. salmiana were diluted in 15 mL of sterile water and added to Syn-A.salmiana products.
Primary Outcome Measure Information:
Title
Gut bacteria associated with changes of the intervention group
Description
Comparison of the log2ratio of the genera and the abundance of amplicon sequence variants across the different treatments.
Time Frame
Abundance of microbes and relative number of taxa in samples through study completion, 6 weeks intervention of each group
Title
Effect of probiotic and synbiotic products intervention on the BMI z-score
Description
Assesment of BMI-Z score changes
Time Frame
Comparison of BMI-Z score through study completion, 6 weeks intervention of each group.
Title
Effect of probiotic and synbiotic products intervention on the fat percentage
Description
Assesment of fat percentage changes
Time Frame
Comparison of fat percentage through study completion, 6 weeks intervention of each group.
Title
Effect of probiotic and synbiotic products intervention on waist and neck circunference
Description
Assesment of waist and neck circunference changes
Time Frame
Comparison of waist and neck circunference through study completion, 6 weeks intervention of each group.
Title
Effect of probiotic and synbiotic products intervention on glucose, triglycerides and cholesterol serum levels
Description
Assesment of glucose, triglycerides and cholesterol serum levels changes
Time Frame
Comparison of glucose, triglycerides and cholesterol serum levels through study completion, 6 weeks intervention of each group.
Secondary Outcome Measure Information:
Title
Effect of probiotic and synbiotic products intervention on Free Fatty Acid Receptors (FFAR) 2 and 3 levels
Description
Assessment of mRNA levels of FFAR2 and FFAR3 in the peripheral blood mononuclear cells changes
Time Frame
Comparison of mRNA levels of FFAR2 and FFAR3 through study completion, 6 weeks intervention of each group.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
6 Years
Maximum Age & Unit of Time
11 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Children were overweight or obese, according to the World Health Organization (≥85th body mass index (BMI) percentile for overweight, and ≥95th BMI percentile for obesity). Exclusion Criteria: Any known infections, systemic diseases or metabolic diseases, and use of any prescribed medications or antibiotics in the one month before randomization and during the trial.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Diana Patricia Portales-Pérez, phD
Organizational Affiliation
Universidad Autónoma de San Luis Potosí
Official's Role
Principal Investigator
Facility Information:
Facility Name
Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí
City
San Luis Potosí
ZIP/Postal Code
78210
Country
Mexico

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
21521545
Citation
Nagata S, Asahara T, Ohta T, Yamada T, Kondo S, Bian L, Wang C, Yamashiro Y, Nomoto K. Effect of the continuous intake of probiotic-fermented milk containing Lactobacillus casei strain Shirota on fever in a mass outbreak of norovirus gastroenteritis and the faecal microflora in a health service facility for the aged. Br J Nutr. 2011 Aug;106(4):549-56. doi: 10.1017/S000711451100064X. Epub 2011 Apr 27.
Results Reference
background
PubMed Identifier
27771020
Citation
Fernandes R, do Rosario VA, Mocellin MC, Kuntz MGF, Trindade EBSM. Effects of inulin-type fructans, galacto-oligosaccharides and related synbiotics on inflammatory markers in adult patients with overweight or obesity: A systematic review. Clin Nutr. 2017 Oct;36(5):1197-1206. doi: 10.1016/j.clnu.2016.10.003. Epub 2016 Oct 8.
Results Reference
background
PubMed Identifier
32455193
Citation
Regalado-Renteria E, Aguirre-Rivera JR, Godinez-Hernandez CI, Garcia-Lopez JC, Oros-Ovalle AC, Martinez-Gutierrez F, Martinez-Martinez M, Ratering S, Schnell S, Ruiz-Cabrera MA, Juarez-Flores BI. Effects of Agave Fructans, Inulin, and Starch on Metabolic Syndrome Aspects in Healthy Wistar Rats. ACS Omega. 2020 May 6;5(19):10740-10749. doi: 10.1021/acsomega.0c00272. eCollection 2020 May 19.
Results Reference
background
PubMed Identifier
23510724
Citation
Larsen N, Vogensen FK, Gobel RJ, Michaelsen KF, Forssten SD, Lahtinen SJ, Jakobsen M. Effect of Lactobacillus salivarius Ls-33 on fecal microbiota in obese adolescents. Clin Nutr. 2013 Dec;32(6):935-40. doi: 10.1016/j.clnu.2013.02.007. Epub 2013 Mar 4.
Results Reference
background
Citation
Martinez-Gutierrez, F., Ratering, S., Juárez-Flores, B., et al. Potential use of Agave salmiana as a prebiotic that stimulates the growth of probiotic bacteria. Lwt, 2017; 84:151-159.
Results Reference
background
PubMed Identifier
28618860
Citation
Nagata S, Chiba Y, Wang C, Yamashiro Y. The effects of the Lactobacillus casei strain on obesity in children: a pilot study. Benef Microbes. 2017 Aug 24;8(4):535-543. doi: 10.3920/BM2016.0170. Epub 2017 Jun 16.
Results Reference
background
PubMed Identifier
23477506
Citation
Safavi M, Farajian S, Kelishadi R, Mirlohi M, Hashemipour M. The effects of synbiotic supplementation on some cardio-metabolic risk factors in overweight and obese children: a randomized triple-masked controlled trial. Int J Food Sci Nutr. 2013 Sep;64(6):687-93. doi: 10.3109/09637486.2013.775224. Epub 2013 Mar 12.
Results Reference
background

Learn more about this trial

Assessment of the Effects of Synbiotic on Gut Microbiota Composition in Scholars With Overweight

We'll reach out to this number within 24 hrs